Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

CUSTOM-MADE NEURONS FOR CELL THERAPY IN PARKINSON’S AND HUNTINGTON’S DISEASE

Project description

Tailored therapies for Parkinson’s and Huntington’s disease

Increased life expectancy has led to more age-related neurodegenerative diseases, challenging the brain’s regenerative capacity. Stem cell therapies show promise in treating neuronal loss in Parkinson’s and Huntington’s disease. Still, their benefits are limited by a generic approach that does not address individual patient needs. The ERC-funded Custom-Made project aims to develop tailored stem cell therapies. It will integrate stem cell technologies, genomics, and bioengineering to create specialised grafts of therapeutic neurons and supportive cells. It will refine graft connectivity in preclinical models and utilise a humanised 3D bioengineered system for in-depth studies on graft integration. Additionally, the project will innovate self-regulating cell products and introduce grafts with disease-modifying properties.

Objective

The rising incidence of age-associated neurodegenerative diseases, due to increased life expectancy, poses a challenge to the brain's limited regenerative capabilities. Stem cell-based therapies offer promise for addressing crucial neuron loss, particularly in Parkinson’s and Huntington’s diseases (PD and HD). Ongoing first-generation stem cell trials, replacing damaged neurons with healthy ones, represent a notable advancement. However, their impact is constrained by a ‘one-cell-fits-all’ generic therapy that does not take in account the diverse clinical needs due to variations in disease etiology, stage, patient heterogeneity, and daily fluctuations in graft requirements.
CUSTOM-MADE is a transformative initiative advancing knowledge and crafting a tailored portfolio of stem cell products for individual patients or patient subgroups, notably targeting PD and HD. Integrating stem cell technologies, genomics and bioengineering, CUSTOM-MADE develops rational graft composites of therapeutic neurons and complementary cells to meet the clinical needs of individual patients. Moving into preclinical animal models, the project refines graft connectivity and functional recovery post-transplantation. A groundbreaking leap involves modeling circuitry reconstruction in a fully humanized 3D in-vitro bioengineered system - the connectoids, allowing detailed studies at cellular and molecular levels for defining factors controlling correct and functional graft integration. For increased translatability, CUSTOM-MADE pioneers the generation of cell products whose activity can be self-regulated or tuned to the patients’ individual requirements. The project implements strategic measures to shield grafts from pathology and introduces the innovative concept of grafted cells exhibiting disease-modifying activity. In essence, CUSTOM-MADE drives the field toward customized stem-cell therapies for PD and HD, marking a paradigm shift in the treatment landscape of neurodegenerative diseases.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-SYG - HORIZON ERC Synergy Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-SyG

See all projects funded under this call

Host institution

UNIVERSITA DEGLI STUDI DI MILANO
Net EU contribution
€ 2 500 000,00
Address
Via Festa Del Perdono 7
20122 Milano
Italy
Region
Nord-Ovest Lombardia Milano
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 500 000,00

Beneficiaries (4)